Leqembi IQLIK is an injectable subcutaneous, or under-the-skin, formulation of the approved Alzheimer’s drug Leqembi. Rather than requiring biweekly infusions in the clinic, Leqembi Iqlik is administered at home through two injections per sitting, each week.